Viewing Study NCT02594267


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-10 @ 2:34 AM
Study NCT ID: NCT02594267
Status: COMPLETED
Last Update Posted: 2021-07-27
First Post: 2015-09-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)
Sponsor: Acrotech Biopharma Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral T-Cell Lymphoma (PTCL) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PTCL View
None Peripheral T-Cell Lymphoma View
None Folotyn View
None Pralatrexate View
None CHOP View